These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11368282)

  • 1. Vaccines without thiomersal: why so necessary, why so long coming?
    van't Veen AJ
    Drugs; 2001; 61(5):565-72. PubMed ID: 11368282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ; McIntyre PB
    Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiomersal-containing vaccines - a review of the current state of knowledge.
    Gołoś A; Lutyńska A
    Przegl Epidemiol; 2015; 69(1):59-64, 157-61. PubMed ID: 25862449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.
    Bigham M; Copes R
    Drug Saf; 2005; 28(2):89-101. PubMed ID: 15691220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiomersal in vaccines: is removal warranted?
    Clements CJ; Ball LK; Ball R; Pratt RD
    Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ
    Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.
    Pichichero ME; Cernichiari E; Lopreiato J; Treanor J
    Lancet; 2002 Nov; 360(9347):1737-41. PubMed ID: 12480426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thiomersal and immunisations].
    Weisser K; Bauer K; Volkers P; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Dec; 47(12):1165-74. PubMed ID: 15583887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiomersal as a vaccine preservative.
    Wkly Epidemiol Rec; 2000 Jan; 75(2):12-6. PubMed ID: 10697462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiomersal allergy and vaccination reactions.
    Cox NH; Forsyth A
    Contact Dermatitis; 1988 Apr; 18(4):229-33. PubMed ID: 3378430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J; Golding J;
    Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvants and additives in vaccines--medical relevance].
    Wiedermann-Schmidt U; Maurer W
    Wien Klin Wochenschr; 2005 Aug; 117(15-16):510-9. PubMed ID: 16160800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness.
    Geier DA; Sykes LK; Geier MR
    J Toxicol Environ Health B Crit Rev; 2007 Dec; 10(8):575-96. PubMed ID: 18049924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
    N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thimerosal in vaccines - white, black, or quite the opposite?
    Rada G
    Medwave; 2014 Mar; 14(2):e5929. PubMed ID: 25198357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disinformation about the risks of adverse effect for children and fetuses of thiomersal in the vaccine].
    Berlin M
    Lakartidningen; 2009 Dec; 106(52):3521. PubMed ID: 20151514
    [No Abstract]   [Full Text] [Related]  

  • 18. Total mercury content in canine hair before and after administration of vaccines containing thiomersal.
    Sedlackova L; Kral T; Sevcikova M; Kruzikova K; Svobodova Z
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():90-4. PubMed ID: 24362099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thimerosal exposure and disturbance of emotions specific to childhood and adolescence: A case-control study in the Vaccine Safety Datalink (VSD) database.
    Geier DA; Kern JK; Homme KG; Geier MR
    Brain Inj; 2017; 31(2):272-278. PubMed ID: 28102704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK; Schwartz B; Todd J; Pickering LK
    Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.